$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 21 2014 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Sell | S | 49.00 | 5,000 | 245,000 | 20,086 | 25.1 K to 20.1 K (-19.93 %) |
Jan 21 2014 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 7.35 | 15,000 | 110,250 | 25,086 | 10.1 K to 25.1 K (+148.72 %) |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 35.48 | 7,187 | 254,995 | 21,563 | |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 35.72 | 8,437 | 301,370 | 14,063 | |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 49.48 | 7,187 | 355,613 | 20,000 | 27.2 K to 20 K (-26.44 %) |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 35.48 | 7,187 | 254,995 | 27,187 | 20 K to 27.2 K (+35.94 %) |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 49.72 | 8,437 | 419,488 | 20,000 | 28.4 K to 20 K (-29.67 %) |
Jan 21 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 35.72 | 8,437 | 301,370 | 28,437 | 20 K to 28.4 K (+42.19 %) |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 7.35 | 100,000 | 735,000 | 100,000 | |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Sell | S | 49.75 | 25,000 | 1,243,750 | 37,220 | 62.2 K to 37.2 K (-40.18 %) |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Sell | S | 49.50 | 25,000 | 1,237,500 | 62,220 | 87.2 K to 62.2 K (-28.66 %) |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Sell | S | 49.25 | 25,000 | 1,231,250 | 87,220 | 112.2 K to 87.2 K (-22.28 %) |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Sell | S | 49.00 | 25,000 | 1,225,000 | 112,220 | 137.2 K to 112.2 K (-18.22 %) |
Jan 21 2014 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 7.35 | 100,000 | 735,000 | 137,220 | 37.2 K to 137.2 K (+268.67 %) |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 625 | 0 | 5,000 | |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 45.75 | 275 | 12,581 | 3,423 | 3.7 K to 3.4 K (-7.44 %) |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 625 | 0 | 3,698 | 3.1 K to 3.7 K (+20.34 %) |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 39.09 | 235 | 9,186 | 3,073 | 3.3 K to 3.1 K (-7.10 %) |
Jan 06 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 625 | 0 | 3,308 | 2.7 K to 3.3 K (+23.29 %) |
Jan 06 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 9,574 | 0 | 19,176 | |
Jan 06 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 45.66 | 6,357 | 290,244 | 20,000 | 26.4 K to 20 K (-24.12 %) |
Jan 06 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Payment of Exercise | F | 45.86 | 3,217 | 147,532 | 26,357 | 29.6 K to 26.4 K (-10.88 %) |
Jan 06 2014 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 0.00 | 9,574 | 0 | 29,574 | 20 K to 29.6 K (+47.87 %) |
Jan 03 2014 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 1,042 | 0 | 3,124 | |
Jan 03 2014 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 45.86 | 458 | 21,004 | 10,086 | 10.5 K to 10.1 K (-4.34 %) |
Jan 03 2014 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 1,042 | 0 | 10,544 | 9.5 K to 10.5 K (+10.97 %) |
Jan 03 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 20.47 | 2,437 | 49,885 | 3,251 | |
Jan 03 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 46.61 | 100 | 4,661 | 2,683 | 2.8 K to 2.7 K (-3.59 %) |
Jan 03 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 45.89 | 2,337 | 107,239 | 2,783 | 5.1 K to 2.8 K (-45.64 %) |
Jan 03 2014 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 20.47 | 2,437 | 49,885 | 5,120 | 2.7 K to 5.1 K (+90.83 %) |
Jan 03 2014 | CPHD | CEPHEID | Fitzgerald Mike | EVP, Global Human R ... | Option Exercise | A | 0.00 | 4,000 | 0 | 4,000 | |
Jan 03 2014 | CPHD | CEPHEID | Fitzgerald Mike | EVP, Global Human R ... | Option Exercise | A | 46.67 | 40,000 | 1,866,880 | 40,000 | |
Dec 24 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
Dec 24 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 47.15 | 100 | 4,715 | 20,000 | 20.1 K to 20 K (-0.50 %) |
Dec 24 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 46.50 | 9,900 | 460,357 | 20,100 | 30 K to 20.1 K (-33.00 %) |
Dec 24 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 0.00 | 10,000 | 0 | 30,000 | 20 K to 30 K (+50.00 %) |
Dec 16 2013 | CPHD | CEPHEID | Post Jim | EVP, NA Commercial ... | Option Exercise | A | 44.96 | 100,000 | 4,496,000 | 100,000 | |
Dec 16 2013 | CPHD | CEPHEID | Post Jim | EVP, NA Commercial ... | Option Exercise | A | 0.00 | 8,333 | 0 | 8,333 | |
Dec 02 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 31.49 | 21,328 | 671,512 | 12,797 | |
Dec 02 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 45.49 | 21,328 | 970,211 | 20,000 | 41.3 K to 20 K (-51.61 %) |
Dec 02 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 31.49 | 21,328 | 671,512 | 41,328 | 20 K to 41.3 K (+106.64 %) |
Nov 18 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 20.47 | 13,813 | 282,752 | 5,688 | |
Nov 18 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 42.70 | 13,813 | 589,815 | 2,683 | 16.5 K to 2.7 K (-83.74 %) |
Nov 18 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 20.47 | 13,813 | 282,752 | 16,496 | 2.7 K to 16.5 K (+514.83 %) |
Nov 13 2013 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Option Exercise | M | 9.26 | 12,500 | 115,750 | 0 | |
Nov 13 2013 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Sell | S | 41.44 | 12,500 | 517,939 | 8,650 | 21.2 K to 8.7 K (-59.10 %) |
Nov 13 2013 | CPHD | CEPHEID | RENTON HOLLINGS | Director | Buy | M | 9.26 | 12,500 | 115,750 | 21,150 | 8.7 K to 21.2 K (+144.51 %) |
Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 0 | |
Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 42.18 | 5,000 | 210,900 | 645 | 5.6 K to 645 (-88.57 %) |
Nov 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
Nov 13 2013 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 41.57 | 357 | 14,840 | 5,714 | 5.4 K to 5.7 K (+6.66 %) |
Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 5,000 | |
Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 41.76 | 5,000 | 208,800 | 645 | 5.6 K to 645 (-88.57 %) |
Nov 13 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
Nov 13 2013 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 41.57 | 608 | 25,275 | 227,806 | 227.2 K to 227.8 K (+0.27 %) |
Nov 13 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 41.57 | 460 | 19,122 | 27,795 | 27.3 K to 27.8 K (+1.68 %) |
Nov 13 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 41.57 | 339 | 14,092 | 79,856 | 79.5 K to 79.9 K (+0.43 %) |
Nov 06 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Option Exercise | M | 11.85 | 12,500 | 148,125 | 0 | |
Nov 06 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Sell | S | 41.00 | 12,500 | 512,500 | 27,335 | 39.8 K to 27.3 K (-31.38 %) |
Nov 06 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 11.85 | 12,500 | 148,125 | 39,835 | 27.3 K to 39.8 K (+45.73 %) |
Oct 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 313 | 0 | 625 | |
Oct 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 40.91 | 164 | 6,709 | 9,502 | 9.7 K to 9.5 K (-1.70 %) |
Oct 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 313 | 0 | 9,666 | 9.4 K to 9.7 K (+3.35 %) |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 10,000 | |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 677 | |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 41.35 | 5,000 | 206,750 | 645 | 5.6 K to 645 (-88.57 %) |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,645 | 645 to 5.6 K (+775.19 %) |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.91 | 177 | 7,241 | 645 | 822 to 645 (-21.53 %) |
Oct 30 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 822 | 483 to 822 (+70.19 %) |
Oct 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
Oct 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 40.91 | 470 | 19,228 | 2,683 | 3.2 K to 2.7 K (-14.91 %) |
Oct 30 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 3,153 | 1.9 K to 3.2 K (+65.69 %) |
Oct 30 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 20.47 | 2,500 | 51,175 | 2,500 | |
Oct 30 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 40.52 | 2,500 | 101,289 | 20,000 | 22.5 K to 20 K (-11.11 %) |
Oct 30 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 20.47 | 2,500 | 51,175 | 22,500 | 20 K to 22.5 K (+12.50 %) |
Oct 30 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 40.25 | 160 | 6,440 | 20,000 | 20.2 K to 20 K (-0.79 %) |
Oct 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 1,250 | 0 | 2,500 | |
Oct 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Payment of Exercise | F | 40.91 | 653 | 26,714 | 37,220 | 37.9 K to 37.2 K (-1.72 %) |
Oct 30 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 0.00 | 1,250 | 0 | 37,873 | 36.6 K to 37.9 K (+3.41 %) |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 250 | 0 | 1,500 | |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 156 | 0 | 1,563 | |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 40.48 | 131 | 5,303 | 9,353 | 9.5 K to 9.4 K (-1.38 %) |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 250 | 0 | 9,484 | 9.2 K to 9.5 K (+2.71 %) |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 40.26 | 82 | 3,301 | 9,234 | 9.3 K to 9.2 K (-0.88 %) |
Oct 28 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 156 | 0 | 9,316 | 9.2 K to 9.3 K (+1.70 %) |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 1,812 | |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 3,385 | |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.48 | 158 | 6,396 | 483 | 641 to 483 (-24.65 %) |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 641 | 339 to 641 (+89.09 %) |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 40.26 | 177 | 7,126 | 339 | 516 to 339 (-34.30 %) |
Oct 28 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 516 | 177 to 516 (+191.53 %) |
Oct 28 2013 | CPHD | CEPHEID | MORTON DEAN O | Director | Option Exercise | M | 11.85 | 12,500 | 148,125 | 0 | |
Oct 28 2013 | CPHD | CEPHEID | MORTON DEAN O | Director | Sell | S | 40.26 | 12,500 | 503,231 | 15,650 | 28.2 K to 15.7 K (-44.40 %) |
Oct 28 2013 | CPHD | CEPHEID | MORTON DEAN O | Director | Buy | M | 11.85 | 12,500 | 148,125 | 28,150 | 15.7 K to 28.2 K (+79.87 %) |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 250 | 0 | 1,500 | |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 339 | 0 | 3,385 | |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 40.48 | 94 | 3,805 | 1,903 | 2 K to 1.9 K (-4.71 %) |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 250 | 0 | 1,997 | 1.7 K to 2 K (+14.31 %) |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 40.26 | 128 | 5,153 | 1,747 | 1.9 K to 1.7 K (-6.83 %) |
Oct 28 2013 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 339 | 0 | 1,875 | 1.5 K to 1.9 K (+22.07 %) |
Oct 28 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 40.07 | 3,000 | 120,210 | 379,800 | 382.8 K to 379.8 K (-0.78 %) |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 237 | 0 | 1,422 | |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 156 | 0 | 1,563 | |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Payment of Exercise | F | 40.48 | 77 | 3,117 | 20,160 | 20.2 K to 20.2 K (-0.38 %) |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 0.00 | 237 | 0 | 20,237 | 20 K to 20.2 K (+1.19 %) |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Payment of Exercise | F | 40.26 | 55 | 2,214 | 20,000 | 20.1 K to 20 K (-0.27 %) |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Buy | M | 0.00 | 156 | 0 | 20,055 | 19.9 K to 20.1 K (+0.78 %) |
Oct 28 2013 | CPHD | CEPHEID | FLOM KERRY | EVP, Regulatory Aff ... | Sell | S | 39.79 | 101 | 4,019 | 19,899 | 20 K to 19.9 K (-0.50 %) |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 1,563 | 0 | 9,375 | |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Option Exercise | M | 0.00 | 1,063 | 0 | 10,625 | |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Payment of Exercise | F | 40.48 | 816 | 33,032 | 36,623 | 37.4 K to 36.6 K (-2.18 %) |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 0.00 | 1,563 | 0 | 37,439 | 35.9 K to 37.4 K (+4.36 %) |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Payment of Exercise | F | 40.26 | 555 | 22,344 | 35,876 | 36.4 K to 35.9 K (-1.52 %) |
Oct 28 2013 | CPHD | CEPHEID | BISHOP JOHN L | Chairman of the Boa ... | Buy | M | 0.00 | 1,063 | 0 | 36,431 | 35.4 K to 36.4 K (+3.01 %) |
Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 20,000 | 238,800 | 15,000 | |
Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.94 | 5,000 | 204,700 | 177 | 5.2 K to 177 (-96.58 %) |
Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.53 | 5,000 | 202,650 | 5,177 | 10.2 K to 5.2 K (-49.13 %) |
Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 40.45 | 10,000 | 404,500 | 10,177 | 20.2 K to 10.2 K (-49.56 %) |
Oct 22 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 20,000 | 238,800 | 20,177 | 177 to 20.2 K (+11,299.44 %) |
Sep 26 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 38.97 | 3,000 | 116,912 | 382,800 | 385.8 K to 382.8 K (-0.78 %) |
Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 35,000 | |
Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 39.34 | 5,000 | 196,700 | 177 | 5.2 K to 177 (-96.58 %) |
Sep 19 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 40,000 | |
Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.95 | 5,000 | 194,750 | 177 | 5.2 K to 177 (-96.58 %) |
Sep 18 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 5,000 | 59,700 | 45,000 | |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 11.94 | 10,000 | 119,400 | 50,000 | |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.35 | 5,000 | 36,750 | 0 | |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.56 | 5,000 | 192,800 | 177 | 5.2 K to 177 (-96.58 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 5,000 | 59,700 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 38.18 | 5,000 | 190,900 | 177 | 5.2 K to 177 (-96.58 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.80 | 5,000 | 189,000 | 5,177 | 10.2 K to 5.2 K (-49.13 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.43 | 5,000 | 187,150 | 10,177 | 15.2 K to 10.2 K (-32.94 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 11.94 | 10,000 | 119,400 | 15,177 | 5.2 K to 15.2 K (+193.16 %) |
Sep 09 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.35 | 5,000 | 36,750 | 5,177 | 177 to 5.2 K (+2,824.86 %) |
Aug 28 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 36.73 | 182 | 6,686 | 385,800 | 386 K to 385.8 K (-0.05 %) |
Aug 28 2013 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 36.36 | 2,818 | 102,466 | 385,982 | 388.8 K to 386 K (-0.72 %) |
Sep 04 2013 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 36.62 | 5,129 | 187,824 | 177 | 5.3 K to 177 (-96.66 %) |
Aug 23 2013 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 35.97 | 414 | 14,892 | 5,357 | 4.9 K to 5.4 K (+8.38 %) |
Aug 23 2013 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 35.97 | 749 | 26,942 | 227,198 | 226.4 K to 227.2 K (+0.33 %) |
Aug 23 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 35.97 | 393 | 14,136 | 79,517 | 79.1 K to 79.5 K (+0.50 %) |
Aug 23 2013 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 35.97 | 533 | 19,172 | 27,335 | 26.8 K to 27.3 K (+1.99 %) |
Aug 22 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 8.65 | 7,500 | 64,875 | 0 | |
Aug 22 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Sell | S | 35.01 | 7,500 | 262,550 | 79,124 | 86.6 K to 79.1 K (-8.66 %) |
Aug 22 2013 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 8.65 | 7,500 | 64,875 | 86,624 | 79.1 K to 86.6 K (+9.48 %) |
Jul 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Option Exercise | M | 0.00 | 312 | 0 | 938 | |
Jul 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Payment of Exercise | F | 34.44 | 163 | 5,614 | 9,070 | 9.2 K to 9.1 K (-1.77 %) |
Jul 30 2013 | CPHD | CEPHEID | SMITH JOSEPH H | EVP, Bus Dev and GC | Buy | M | 0.00 | 312 | 0 | 9,233 | 8.9 K to 9.2 K (+3.50 %) |